{"name":"Graviton Bioscience Corporation","slug":"graviton-bioscience-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQSjVJNFQwdGxjUGRqbTFKdFhXdWdVZUpDTmFHMS1WSmduakNnVjNpandOYXExNnJtR25SWG1zMFdxWUxzc0o4bzlLOWdWa3VsUVRkSDZIM0dGS3hNcGVnSm9GVE1hMDEtdHluVTNha3AwMjBpR09WS1BBNExGQ2lmb0M5Si1kOGxad3BzUFhyNS04RW9IaG9NbHlldUluc3BJZC1YVUhiTXdFTVhPdWhqYWFBYlJZMTRzWU9oaHVucTNzcGw1bElETlk1QklEejRHOVhFRmJIb1BKei1ONnJfZ1JueDgzdk0wLUxDT0xXcm1iZw?oc=5","date":"2025-11-20","type":"trial","source":"PR Newswire","summary":"Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference - PR Newswire","headline":"Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPMUtVRC0zX3d4eEFNMGItRGJ3M00wVnVkSzdjcGZhM3pXUXhoR1dLYS1EYjJwUGZWdmFFYjlOQWlzbTk1WmxlWXA0OG1SaGd3S0VZSU1CTy1RbmVkYzVDRlM3Y19tblNTY2EyTTNWSmxGbFBYX1Rvdy1tYVNsQk10SzFVMFdXMGdfT2NkUE9wY1Byd25XdHhick8zeGdBdzFUbk9HRUdqbzZPUEVzRWtJcmZJVXpWenRjb3Uwc1hXTjhWS05KdXEyU3B5NkFXVEE?oc=5","date":"2025-04-25","type":"pipeline","source":"New York Post","summary":"Biotech mogul Sam Waksal of Martha Stewart fame accused of testing illegal 'swine drug' on child - New York Post","headline":"Biotech mogul Sam Waksal of Martha Stewart fame accused of testing illegal 'swine drug' on child","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOLWpoT1FpRVBTaWxNMWlIRXd6NjdLN0dIR0o4eWVJQ2d2blAzcGlMcFdSa05xNTBfRmZleXJfMEVBVzJoTkMxU0xiOVhkSHpFa1paT0J6dkRsVDJBelFuVUV6N29nRUFXVVVMZ0poSzA2dmJkVWVPbmtnQ0JsWXRaODhIV2xaWURaRjJPOHd0cVFPT1NaTVdKc0VYeXZvZ2xGVnJnRHF2X09DejFqamE4Qmx1OUVHa1FrdXVvWFRNMTdEaXloM0J5WGdDZDFlc1JPNFREZUNRUHFNRmJKWGxVVWplb0FKNkZlNG9XQjBQYVJpUnEzVllIdnl0WUFrd3FHVVd1TFoydm9KVTRvNG5NalQ3b2RYdDVSZzR4OXg1aw?oc=5","date":"2024-02-01","type":"pipeline","source":"PR Newswire","summary":"Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors - PR Newswire","headline":"Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selectiv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQTGZxbS1nb0xFZ0RVUjFXOVlYQUhDM0dfWE5TYk9vU3ZDVExjSm5XcWl4Y1RsVjJ3a1UzSG1zTzNjVWNUeGVjOXBKdUhTNE1SbGpFa21peTVCbzhGZ1BsZkgwSWxZOFFuRFptTzZ1MHA4WXpyVDBtdml6UV9adHNyYWJNbkFDRnZlcDF3?oc=5","date":"2024-02-01","type":"pipeline","source":"Contract Pharma","summary":"Sanofi Invests in Graviton Bioscience - Contract Pharma","headline":"Sanofi Invests in Graviton Bioscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNcVVfaVdHd3Qtc0VNU2o3RV9tNlIzeVhPZDRvSGV2bkJ1LWx0Yzh2bnQzZVJicHI5cHRXRGRabVY4MlVRMDNFMFR5M2hiZG5XVVg0blU4NE84ajZxenJPNThYSnBvMlA2Z1NRVVFyOFp3MFRiWEhjcGdSSHh1eVhpcHdSUjNINHYxbDVTWmFRaC04M1p4ZFF5UHh6cGNxbDV0U0xBejAtd001OTdob1AyXzZUbUJIZlQzb3p0bGlSWWpOa1NTS1FHRUMxRVMxNEpNUmxyRmJfald5LTI4NjJxTVRWYW9xUVRsMDl3WGhJVVYtQ2pYRFk0SHJ6UFg1STg?oc=5","date":"2024-01-02","type":"pipeline","source":"PR Newswire","summary":"Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors - PR Newswire","headline":"Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQejJRNHN2QS15X1B0S2tsSkVxTkl4MXpnZ3hSY0V3TzZDVG9mUTEyeUFiSU1IQTQ1VFFZYjNqaWVGZVRjcnFlVEhXRllEVHY5Wlplamp0SjM1QTlDRG5rTk1zRUQwbzJYaXNyN2lBYVRGLWpMNnZjOXFZUDVLek1TY0lrd2E1eTh1V1FmanVrYVVZZmlxZmhTZlJKMlljaHlObEhaanhFX1BoTVZNcE5MTW1DZGM1NHNzZmdWMjFUbndHMmc?oc=5","date":"2023-05-01","type":"pipeline","source":"Fierce Biotech","summary":"Ovid snaps up Rock2 inhibitor from Sam Waksal-led biotech, continuing climb through neurological terrain - Fierce Biotech","headline":"Ovid snaps up Rock2 inhibitor from Sam Waksal-led biotech, continuing climb through neurological terrain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE03ZHNDSXl5aHJoM0xqaU5FRXBqMndYQjlHd25PaUN0dmktdjcxN0tPRnZxNnlfMXBWdGRCVGNBaG82MGRNWmJxN1pxXzUydnhzNTdQdXNBSjNEZlVhRGllVkFHRURQTWdkNldtdWVnejN6MEVhR3VIcEtsMkJPQQ?oc=5","date":"2022-03-09","type":"trial","source":"China Daily","summary":"Sino Biopharm announces clinical trials for pneumoconiosis drug - China Daily","headline":"Sino Biopharm announces clinical trials for pneumoconiosis drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNaUI4MmYxdU1iYW5hb2lRdkxLTkdFUlNXUWktN0JiLTZ1Q3RIUkZpaGFYLVFrNGs2dDQ0d1Y4QVEydXRoeXBMMV9mRmcweVZhQTVBbjVJdVVrcE5laERGRm1lclhrTW9WUktNaUZEY3g4djhOMTlJTGVoTkFROHFNUDZjQVNzUDlZWm5yLXhpT0U5cFYySk50SEFuV29vOWdVNC15THM2aWxHSnpXdHFBNURIVl91dmJIUVlmVG54MDRwZC1wN3QwdFdlU2FUcG8xV2NkWFltUnQ?oc=5","date":"2021-02-23","type":"pipeline","source":"PR Newswire","summary":"Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide - PR Newswire","headline":"Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}